Medtronic Execs Pin Growth Plans On Diabetes, Robotic Surgery

After reporting a $1 million loss for the same period one year earlier, Medtronic defied analysts’ expectations to bounce back and earn $1.1 billion in the fourth quarter ended April 29, boosted by the acquisition of Covidien. Strong demand for cardiovascular and diabetes device sales paced all product segments during the period. http://www.meddeviceonline.com/doc/medtronic-execs-pin-growth-plans-on-diabetes-robotic-surgery-0001